Maternal antecedents for cerebral palsy in extremely preterm babies: A case-control study

Developmental Medicine and Child Neurology

Volumn 43, Issue 9, 2001, Pages 580-585

  Gray, Peter H ^a   Jones, Peter ^a   O'Callaghan, Michael J ^b  

^a MATER MOTHERS HOSPITAL   (Australia)

^b MATER CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID DERIVATIVE; RITODRINE; SALBUTAMOL; UTERUS SPASMOLYTIC AGENT;

ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CHORIOAMNIONITIS; CLINICAL ARTICLE; DRUG USE; GESTATIONAL AGE; HIGH RISK POPULATION; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; MATERNAL DISEASE; OBSTETRIC CARE; PLACENTA DISORDER; PREECLAMPSIA; PREMATURITY; PRENATAL CARE; PRENATAL DIAGNOSIS; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL; UMBILICAL CORD;

EID: 0034842102     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2001.tb00240.x     Document Type: Article

References (37)

1. Impact of intrauterine growth restriction on neurodevelopmental and growth outcomes in very low birthweight infants
2. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very preterm infants
3. Terminology and classification of cerebral palsy
4. New South Wales population-based birthweight percentile charts
5. Spastic diplegia in premature infants: Etiologic and diagnostic considerations
6. Intrapartum asphyxia: A rare cause of cerebral palsy
7. Intrauterine growth and spastic cerebral palsy 1. Association with birth weight for gestational age
8. Some risk factors for cerebral palsy in very premature infants: Importance of premature rupture of membranes and monochorionic twin placentation
9. Effects of antenatal dexamethasone administration in the infant: Long-term follow-up
10. Cerebral palsy in very low birthweight infants
11. Trends in incidence of cranial ultrasound lesions and cerebral palsy in very low birthweight infants 1982-93
12. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled studies
13. Increased risk of spastic diplegia among very low birth weight children after preterm labor or prelabor rupture of membranes
14. Periventricular leukomalacia (PVL) and perinatal infection
15. Survival and neonatal and neurodevelopmental outcome of 24-29 week gestation infants according to primary cause of preterm delivery
16. Maternal hypertension and neurodevelopmental outcome in very preterm infants
17. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants
18. Very preterm birth - A regional study. Part 2: The very preterm infant
19. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant; A randomized placebo-controlled multicenter study
20. An efficient program for computing maximum likelihood estimates and exact confidence limits for a common odds ratio
21. Case-control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies
22. Antecedents of cerebral palsy I. Univariate analysis of risks
23. Prenatal events and risk of cerebral palsy in very low birth weight infants
24. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants
25. Antenatal steroid administration is associated with an improved chance of intact survival in preterm infants
26. Randomised study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years
27. Physical development and medical history of children who were treated antenatally with corticosteroid to prevent respiratory distress syndrome: A 10- to 12-year follow up
28. Antenatal and delivery factors simultaneously associated with neonatal death and cerebral palsy in preterm infants
29. Perinatal outcomes of a large cohort of extremely low gestational age infants (twenty-three to twenty-eight completed weeks of gestation)
30. Intrauterine growth and gestational age in preterm infants with cerebral palsy
31. Intrauterine growth in children with cerebral palsy
32. Study of interleukin-6 and tumour necrosis factor-alpha levels in maternal serum and amniotic fluid of patients with premature rupture of membranes
33. Cerebral palsy: Effects of twinning, birthweight, and gestational age
34. Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children
35. Periventricular leukomalacia: Risk factors revisited